• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿肾盂输尿管连接部梗阻手术成功对尿HIP/PAP和BD-1水平的影响。

Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.

作者信息

Gupta Sudipti, Nicassio Lauren, Junquera Guillermo Yepes, Jackson Ashley R, Fuchs Molly, McLeod Daryl, Alpert Seth, Jayanthi Venkata R, DaJusta Daniel, McHugh Kirk M, Becknell Brian, Ching Christina B

机构信息

Division of Pediatric Urology, Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, USA; Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.

Division of Pediatric Urology, Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, USA.

出版信息

J Pediatr Urol. 2020 Oct;16(5):592.e1-592.e7. doi: 10.1016/j.jpurol.2020.03.006. Epub 2020 Mar 29.

DOI:10.1016/j.jpurol.2020.03.006
PMID:32278658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7529730/
Abstract

INTRODUCTION

In the pediatric patient whose ureteropelvic junction obstruction (UPJO) is not always symptomatic, imaging is the most common means of detecting surgical success. There is interest, however, in other means of post-operative monitoring. A panel of antimicrobial peptides (AMPs) has been previously found to be elevated in UPJO, but the impact of surgical correction on these AMPs is unknown.

OBJECTIVE

To determine if elevated levels of candidate urinary AMP biomarkers of urinary tract obstruction decrease following UPJO repair.

STUDY DESIGN

Pediatric patients undergoing surgical correction of an UPJO were recruited for participation. Bladder urine from uninfected consenting/assenting patients was collected immediately prior to surgery and then at least 6 months afterward. Based on prior studies demonstrating significant elevation of beta defensin 1 (BD-1), hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP), cathelicidin (LL-37), and neutrophil gelatinase-associated lipocalin (NGAL) in patients with UPJO versus control patients, we performed enzyme-linked immunosorbent assays on these four AMPs to compare their expression before and after surgical intervention. If found to significantly decrease, AMP levels were compared to healthy controls. AMP levels were normalized to urine creatinine. Results were analyzed with paired t test or Wilcoxon test using Graphpad software. Correlation was calculated using Pearson or Spearman correlation. A p-value of <0.05 was considered significant.

RESULTS

13 UPJO patients were included in this study; 9 were male (69%). Age at surgery was a median of 4.3 years (average 6.1, range 0.4-18.4 years). Follow-up urine samples were collected a median of 27.4 months after surgery (average 27.4; range 7.8-45.3 months). All 13 patients had clinical improvement and/or signs of improved hydronephrosis on post-operative imaging. HIP/PAP and BD-1 significantly decreased in post-surgical samples compared to pre-surgical samples (p = 0.02 and 0.01, respectively); NGAL and LL-37 did not significantly change. Overall, HIP/PAP decreased in 12 patients (92%) and BD-1 decreased in 11 patients (85%). BD-1 levels after successful repair were not different from healthy controls (p = 0.06).

DISCUSSION

Urinary biomarkers of obstruction should detect significant obstructive pathology as well as reflect its resolution. This would enable their use in post-operative monitoring and augment current methods of determining successful surgical outcome through imaging.

CONCLUSIONS

The AMPs HIP/PAP and BD-1 are significantly elevated in UPJO but then significantly decrease after pyeloplasty, with BD-1 returning to healthy control levels. As a result, these AMPs could serve as markers of successful surgical intervention.

摘要

引言

在输尿管肾盂连接部梗阻(UPJO)并非总是有症状的儿科患者中,影像学检查是检测手术成功与否最常用的方法。然而,人们对术后监测的其他方法也很感兴趣。先前发现一组抗菌肽(AMPs)在UPJO患者中升高,但手术矫正对这些抗菌肽的影响尚不清楚。

目的

确定尿路梗阻候选尿AMPs生物标志物水平在UPJO修复后是否降低。

研究设计

招募接受UPJO手术矫正的儿科患者参与研究。在手术前及术后至少6个月,收集未感染且同意参与的患者的膀胱尿液。基于先前研究表明,与对照患者相比,UPJO患者中β-防御素1(BD-1)、肝癌-肠-胰腺/胰腺炎相关蛋白(HIP/PAP)、杀菌肽(LL-37)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)显著升高,我们对这四种抗菌肽进行酶联免疫吸附测定,以比较手术干预前后它们的表达情况。如果发现显著降低,则将抗菌肽水平与健康对照进行比较。抗菌肽水平以尿肌酐进行标准化。使用Graphpad软件通过配对t检验或Wilcoxon检验分析结果。使用Pearson或Spearman相关性计算相关性。p值<0.05被认为具有统计学意义。

结果

本研究纳入13例UPJO患者;9例为男性(69%)。手术年龄中位数为4.3岁(平均6.1岁;范围0.4 - 18.4岁)。术后尿液样本收集时间中位数为术后27.4个月(平均27.4个月;范围7.8 - 45.3个月)。所有13例患者临床症状均有改善和/或术后影像学检查显示肾盂积水改善迹象。与术前样本相比,术后样本中HIP/PAP和BD-1显著降低(p分别为0.02和0.01);NGAL和LL-37无显著变化。总体而言,12例患者(92%)的HIP/PAP降低,11例患者(85%)的BD-1降低。成功修复后BD-1水平与健康对照无差异(p = 0.06)。

讨论

梗阻性尿路生物标志物应能检测出显著的梗阻性病变并反映其缓解情况。这将使其可用于术后监测,并增强目前通过影像学确定手术成功结果的方法。

结论

抗菌肽HIP/PAP和BD-1在UPJO中显著升高,但肾盂成形术后显著降低,且BD-1恢复至健康对照水平。因此,这些抗菌肽可作为手术成功干预的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa4/7529730/7d4372c7d058/nihms-1580694-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa4/7529730/2de417112634/nihms-1580694-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa4/7529730/7d4372c7d058/nihms-1580694-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa4/7529730/2de417112634/nihms-1580694-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa4/7529730/7d4372c7d058/nihms-1580694-f0003.jpg

相似文献

1
Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.小儿肾盂输尿管连接部梗阻手术成功对尿HIP/PAP和BD-1水平的影响。
J Pediatr Urol. 2020 Oct;16(5):592.e1-592.e7. doi: 10.1016/j.jpurol.2020.03.006. Epub 2020 Mar 29.
2
Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy.尿抗菌肽:梗阻性尿路病的潜在新型生物标志物。
J Pediatr Urol. 2018 Jun;14(3):238.e1-238.e6. doi: 10.1016/j.jpurol.2018.03.006. Epub 2018 Mar 29.
3
Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.尿中性粒细胞明胶酶相关脂质运载蛋白水平与肾盂成形术治疗肾盂输尿管连接部梗阻患者的肾功能差异相关。
J Urol. 2013 Oct;190(4 Suppl):1462-7. doi: 10.1016/j.juro.2013.05.003. Epub 2013 Jun 20.
4
Reoperative robotic pyeloplasty in children.儿童再次手术机器人肾盂成形术
J Pediatr Urol. 2016 Dec;12(6):394.e1-394.e7. doi: 10.1016/j.jpurol.2016.04.045. Epub 2016 Jun 29.
5
Differentiating Asymptomatic Bacteriuria From Urinary Tract Infection in the Pediatric Neurogenic Bladder Population: NGAL As a Promising Biomarker.区分小儿神经源性膀胱人群中的无症状菌尿与尿路感染:中性粒细胞明胶酶相关脂质运载蛋白作为一种有前景的生物标志物
Top Spinal Cord Inj Rehabil. 2019 Summer;25(3):214-221. doi: 10.1310/sci2503-214.
6
Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.先天性肾盂输尿管连接部梗阻患儿尿中脂联素-2、白细胞介素-6 和单核细胞趋化蛋白-1 水平升高。
J Pediatr Urol. 2019 Feb;15(1):44.e1-44.e7. doi: 10.1016/j.jpurol.2018.10.007. Epub 2018 Oct 17.
7
Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.输尿管肾盂连接处梗阻患者膀胱尿液中的近端肾小管蛋白显著升高,可能代表新型生物标志物:一项初步研究。
J Pediatr Urol. 2016 Apr;12(2):120.e1-7. doi: 10.1016/j.jpurol.2015.10.008. Epub 2015 Nov 28.
8
Hydronephrosis: Comparison of extrinsic vessel versus intrinsic ureteropelvic junction obstruction groups and a plea against the vascular hitch procedure.肾积水:外在血管性梗阻与内在肾盂输尿管连接部梗阻组的比较以及对血管牵拉手术的反对意见
J Pediatr Urol. 2015 Apr;11(2):80.e1-6. doi: 10.1016/j.jpurol.2014.10.014. Epub 2015 Mar 4.
9
Urinary biomarkers in hydronephrosis.肾积水的尿液生物标志物
Dan Med J. 2013 Feb;60(2):B4582.
10
Laparoscopic pyeloplasty versus open pyeloplasty for recurrent ureteropelvic junction obstruction in children.腹腔镜肾盂成形术与开放肾盂成形术治疗儿童复发性输尿管肾盂连接处梗阻的比较
J Pediatr Urol. 2016 Dec;12(6):401.e1-401.e6. doi: 10.1016/j.jpurol.2016.06.010. Epub 2016 Jul 21.

引用本文的文献

1
Understanding ureteropelvic junction obstruction: how far have we come?了解肾盂输尿管连接处梗阻:我们取得了多大进展?
Front Urol. 2023 Apr 19;3:1154740. doi: 10.3389/fruro.2023.1154740. eCollection 2023.
2
Cathelicidin in Urinary Tract Diseases: Diagnostic, Prognostic and Therapeutic Potential of an Evolutionary Conserved Antimicrobial Protein.尿路上皮疾病中的cathelicidin:一种进化保守抗菌蛋白的诊断、预后及治疗潜力
Medicina (Kaunas). 2024 Dec 6;60(12):2015. doi: 10.3390/medicina60122015.
3
Serum and urine periostin and cytokeratin-18 in children with congenital obstructive nephropathy.

本文引用的文献

1
Innate immunity and urinary tract infection.先天免疫与尿路感染。
Pediatr Nephrol. 2020 Jul;35(7):1183-1192. doi: 10.1007/s00467-019-04269-9. Epub 2019 Jun 13.
2
The uroplakin plaque promotes renal structural integrity during congenital and acquired urinary tract obstruction.尿路上皮板层在先天性和获得性尿路梗阻中促进肾脏结构完整性。
Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1019-F1031. doi: 10.1152/ajprenal.00173.2018. Epub 2018 Jun 13.
3
Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy.
先天性梗阻性肾病患儿血清和尿液中的骨膜蛋白及细胞角蛋白-18
Cent Eur J Immunol. 2022;47(1):63-72. doi: 10.5114/ceji.2022.115687. Epub 2022 May 10.
4
The use of biomarkers in the diagnosis and treatment of obstruction of the upper urinary tract in children.生物标志物在儿童上尿路梗阻诊断与治疗中的应用
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Sep;166(3):243-250. doi: 10.5507/bp.2022.002. Epub 2022 Feb 3.
5
Longitudinal kidney injury biomarker trajectories in children with obstructive uropathy.梗阻性肾病患儿的纵向肾损伤生物标志物轨迹
Pediatr Nephrol. 2020 Oct;35(10):1907-1914. doi: 10.1007/s00467-020-04602-7. Epub 2020 May 22.
尿抗菌肽:梗阻性尿路病的潜在新型生物标志物。
J Pediatr Urol. 2018 Jun;14(3):238.e1-238.e6. doi: 10.1016/j.jpurol.2018.03.006. Epub 2018 Mar 29.
4
The role of urinary KIM-1, NGAL, CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adults.尿KIM-1、中性粒细胞明胶酶相关脂质运载蛋白、CA19-9及β2-微球蛋白在评估成人肾盂输尿管连接部梗阻中的作用
Biomarkers. 2017 Nov;22(7):682-688. doi: 10.1080/1354750X.2017.1284264. Epub 2017 Feb 8.
5
Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection.HIP/PAP和RegIIIγ抗菌肽在哺乳动物尿路感染中的表达及意义
PLoS One. 2015 Dec 10;10(12):e0144024. doi: 10.1371/journal.pone.0144024. eCollection 2015.
6
Urinary IP-10, MCP-1, NGAL, Cystatin-C, and KIM-1 Levels in Prenatally Diagnosed Unilateral Hydronephrosis: The Search for an Ideal Biomarker.产前诊断的单侧肾积水患者尿中IP-10、MCP-1、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、胱抑素C及肾损伤分子-1(KIM-1)水平:寻找理想生物标志物
Urology. 2016 Jan;87:185-92. doi: 10.1016/j.urology.2015.09.007. Epub 2015 Oct 23.
7
Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.产前肾积水患者尿液中中性粒细胞明胶酶相关脂质运载蛋白、肾损伤分子-1及肝型脂肪酸结合蛋白的浓度
J Pediatr Urol. 2015 Oct;11(5):249.e1-6. doi: 10.1016/j.jpurol.2015.02.021. Epub 2015 Jun 6.
8
Is routine postoperative diuresis renography indicated in all adult patients after pyeloplasty for ureteropelvic junction obstruction?对于所有因肾盂输尿管连接部梗阻接受肾盂成形术的成年患者,术后常规进行利尿肾图检查是否必要?
Urology. 2015 Jan;85(1):246-51. doi: 10.1016/j.urology.2014.09.033.
9
Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.用于梗阻性肾病和临床结局的尿液生物标志物组分析
PLoS One. 2014 Nov 17;9(11):e112865. doi: 10.1371/journal.pone.0112865. eCollection 2014.
10
Emerging urinary markers of renal injury in obstructive nephropathy.梗阻性肾病中肾脏损伤的新型尿液标志物。
Biomed Res Int. 2014;2014:303298. doi: 10.1155/2014/303298. Epub 2014 Jul 2.